Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03469570 · ClinicalTrials.gov registry record · NA
Assisted Fluid Management IDE Study
A NA study, sponsored by Edwards Lifesciences.
- Completed
- Registry status
- NA
- Development phase
- 330
- Enrollment target
NCT03469570: Completed NA study, sponsored by Edwards Lifesciences.
NCT03469570 is a NA study that has completed, run by Edwards Lifesciences. The registered enrollment target is 330 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03469570, a NA study, has completed, sponsored by Edwards Lifesciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 330 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the performance of the Acumen™ Assisted Fluid Management (AFM) Feature in its ability to predict a subject's fluid responsiveness.
Primary Outcome
Stroke volume change meeting the clinician-selected fluid strategy
Interventions
- DEVICE EV1000 Clinical Platform with Assisted Fluid Management (AFM) Feature
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2018-04-19 |
| Est. Completion | 2019-01-25 |
| Phase | NA |
What the finished NCT03469570 record still lists
NCT03469570 is an interventional study that assigns participants to a tested intervention. The registered 330 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower).
The record links to 0 conditions, and to 1 intervention - of which EV1000 Clinical Platform with Assisted Fluid Management (AFM) Feature is the first listed.
NCT03469570 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03469570 about?
NCT03469570 is a clinical study titled "Assisted Fluid Management IDE Study". The primary objective of this study is to evaluate the performance of the Acumen™ Assisted Fluid Management (AFM) Feature in its ability to predict a subject's fluid responsiveness.
What is the current status of trial NCT03469570?
This trial is currently completed. It is a NA study. The enrollment target is 330 participants. The study started on 2018-04-19. Estimated completion is 2019-01-25.
What interventions are being tested in trial NCT03469570?
The interventions under investigation include: EV1000 Clinical Platform with Assisted Fluid Management (AFM) Feature (DEVICE).
Who is sponsoring clinical trial NCT03469570?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03469570's enrollment target sits among peer trials
330 307th of 2000 higher than 1,693 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00359684 · 330 participants
Use of Cysteamine in the Treatment of Cystinosis
- NCT03817502 · 330 participants · Phase 3
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
- NCT03922724 · 330 participants · Phase 2
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
- NCT03932773 · 330 participants · NA
Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI